跳至主要内容
临床试验/JPRN-jRCTs031230490
JPRN-jRCTs031230490招募中Unknown

A randomized controlled trial of anti-inflammatory analgesics after COVID-19 vaccination in Japan

Kobashi Hiroe0 个研究点目标入组 104 人开始时间: 2023年12月4日最近更新:
适应症

试验速览

阶段
Unknown
状态
招募中
发起方
入组人数
104

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 18age old 至 ot applicable(—)
性别
All

入选标准

  • Those who meet all of the following selection criteria and who have obtained consent from the person himself/herself.
  • 1) Over 18 years old
  • 2) Gender: Any
  • 3) Eligible for COVID-19 vaccine booster in accordance with the instructions of the Ministry of Health, Labor and Welfare
  • 4) Healthy or stable chronic condition without major changes in treatment or hospitalization over the past 6 weeks
  • 5) Those who can agree to contraception in order to take drugs on the day of COVID-19 vaccination and the day after that

排除标准

  • Those who meet even one of the following exclusion criteria will be excluded from the target.
  • (1) Persons who have not received mRNA or COVID-19 vaccine
  • (2) Persons who have taken antipyretic analgesics or acetaminophen within 24 hours prior to booster vaccination
  • (3) Patients with a contraindication or history of severe adverse reaction to mRNA or COVID-19 vaccine
  • (4) Allergy or intolerance to acetaminophen
  • 5) Patients on chronic treatment with NSAIDs
  • 6) Patients with peptic ulcer
  • (7) Patients with aspirin asthma or with a history of aspirin asthma
  • (8) Patients with severe cardiac dysfunction
  • (9) Patients with a history of immunodeficiency (including but not limited to CD4 count below 200, progressive hypogammaglobulinemia, CVID)
  • (10) Patients with a history of systemic steroid therapy, active treatment with immunosuppressive agents including DMAR, small molecule drugs used to suppress immune response, biologics, or human blood products in the past 12 months
  • (11) Persons with serious renal disease
  • (12) Persons with serious liver disease
  • (13) Pregnant or lactating mothers
  • (14) Persons deemed unsuitable as subjects by the doctor in charge of conducting the research

研究者

发起方
Kobashi Hiroe

相似试验

已完成
不适用
Post-operative inflammatory and angiogenic response in patients with resectable colon cancer: a randomised clinical trial comparing open versus laparoscopic surgeryMalignant neoplasm of colonColon cancerCancer
ISRCTN55624793Hospital del Mar (Spain)120
进行中(未招募)
2 期
Efficacy of anti-inflammatory drugs in jaw-joint pain in edentulous patients.Temporo-mandibular joint painOther muscular or skeletal disordersMusculoskeletal - Other muscular and skeletal disorders
ACTRN12624000434594Srdjan D. Postic90
进行中(未招募)
1 期
Study of the efficacy and safety of various anti-inflammatory agents in participants with mild cognitive impairment or mild Alzheimer's DiseaseMild cognitive impairment due to Alzheimer’s disease and mild Alzheimer’s diseaseMedDRA version: 20.0Level: LLTClassification code 10001896Term: Alzheimer's diseaseSystem Organ Class: 10029205 - Nervous system disorders
EUCTR2020-003966-38-ISovartis Pharma AG900
进行中(未招募)
1 期
Study of the efficacy and safety of various anti-inflammatory agents in participants with mild cognitive impairment or mild Alzheimer's DiseaseMild cognitive impairment due to Alzheimer’s disease and mild Alzheimer’s diseaseMedDRA version: 20.0Level: LLTClassification code 10001896Term: Alzheimer's diseaseSystem Organ Class: 100000004852
EUCTR2020-003966-38-FIovartis Pharma AG900
进行中(未招募)
不适用
Verification of the anti-inflammatory effect with new PMMA dialyzer "NF" -CNW multicenter trialChronic renal failure
JPRN-UMIN000016567JCHO Chiba Hospital37